the motivation

Over two million patients around the world suffer from End Stage Renal Disease (ESRD). Patients' survival depends on dialysis, a renal replacement therapy that they undergo until they receive a kidney transplant. The survival rate of patients under dialysis is less than 40% in 5 years (1).

A year of dialysis of each patient may cost $82,000 in the United States. Patients endure a lot more hardships due to complications and lifestyle restrictions. Studies show that longer treatment times can potentially be associated with prolonged survival (2).

the solution

We are working on an implantable renal replacement therapy. Our device would reduce several costs associated with dialysis equipment, caregivers and insurance providers. We are creating an opportunity for patients to have access to renal replacement therapy continuously and at all times.

features
Continuous 24/7 access to renal replacement therapy No thrice a week visits to dialysis clinics any more Hassle free travel A more comfortable life
contact us
Email: ma@qidni.com
Twitter: @Qidni
Facebook: Qidni Labs
Youtube: Qidni Labs
Address in USA:
Qidni Labs, Inc.
479 Jessie St
San Francisco, CA
USA 94103
Address in Canada:
Qidni Labs, Inc.
c/o Velocity
151 Charles Street West, Suite 199
Kitchener, Ontario
Canada N2G 1H6